Starboard’s Dynatrace Play: Activist Turnaround or Sale
Starboard Value’s effort at Dynatrace tests whether the observability software maker can turn around on its own or be...
Which Credit Cards Offer Cash Rewards No Annual Fee
Discover credit cards that provide cash rewards without annual fees. Make your spending count!
26,108 articlesSentinelOne Stock Sell After CEO Dump: Is It a Buy or Sell Now?
When a CEO sells a sizable stake, investors take notice. This deep dive looks at what sentinelone stock sell after si...
What Know About This Fund’s Porch Group Purchase: Deep Dive
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
Alphabet Stock Looks Undervalued as AI Push Accelerates
Alphabet stock looks undervalued as the tech giant rides a fresh wave of AI monetization, beating quarterly targets a...
NVIDIA Delivers Fantastic News for Uber Stock Investors
A surge of optimism surrounds NVIDIA's latest driverless advances and what they mean for Uber stock investors. This p...
Apple's Biggest Test Arrives: WWDC 2026 Preview
Investors watch WWDC 2026 with high expectations as Apple readies a major AI push. This preview outlines what’s at st...
Potential Rival Wants Undercut: Investor Guidance Today
A new player in the chip foundry race is signaling aggressive pricing. If a potential rival wants undercut, investors...
Here’s What May Trigger a Short Squeeze for EchoStar
EchoStar joined the S&P 500 on March 23, 2026, carrying unusually high short interest. This article examines the setu...
Broadcom’s Bloodbath: This What Perfection Looks Like
Broadcom beat on revenue but missed AI-growth expectations, sparking a rethink on how investors price AI-driven momen...
Fermi America Sinks 11.5% on $375M Convertible Offering
Fermi America slumped 11.5% as it unveiled a $375 million convertible note offering and reported a Q1 with zero reven...
Bernstein Calls Bitcoin Bottom, Sets 226% Strategy Target
A Bernstein Research note argues Bitcoin has likely formed a cycle bottom and pins a $450 target on Strategy stock, s...
Revolution Medicines This Year: Bulls and Bears for RVMD
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status